Correlation in gene expression between the aggravation of chronic obstructive pulmonary disease and the occurrence of complications

References

• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–2128.
   PubMed Web of Science ®Google Scholar
• Lopez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21:14–23.
   PubMed Web of Science ®Google Scholar
• Fang X, Wang X, Bai C. COPD in China: the burden and importance of proper management. Chest. 2011;139:920–929.
   PubMed Web of Science ®Google Scholar
• Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest. 1995;108(43):S–52S.
   Google Scholar
• Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: impact, measurement and mechanisms. Respirology. 2015;20:1160–1171.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Senescence in COPD and its comorbidities. Annu Rev Physiol. 2017;79:517–539.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165–1185.
   PubMed Web of Science ®Google Scholar
• Cavailles A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22:454–475.
   PubMedGoogle Scholar
• Abdullah M, Schultz H, Kahler D, et al. Expression of the acute phase protein haptoglobin in human lung cancer and tumor-free lung tissues. Pathol Res Pract. 2009;205:639–647.
   PubMed Web of Science ®Google Scholar
• Abdullah M, Kahler D, Vock C, et al. Pulmonary haptoglobin and CD163 are functional immunoregulatory elements in the human lung. Respiration. 2012;83:61–73.
   PubMed Web of Science ®Google Scholar
• Arredouani MS, Kasran A, Vanoirbeek JA, et al. Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo. Immunology. 2005;114:263–271.
   PubMed Web of Science ®Google Scholar
• Jelena A, Mirjana M, Desanka B, et al. Haptoglobin and the inflammatory and oxidative status in experimental diabetic rats: antioxidant role of haptoglobin. J Physiol Biochem. 2013;69:45–58.
   PubMed Web of Science ®Google Scholar
• Arellano-Orden E, Calero-Acuna C, Cordero JA, et al. Specific networks of plasma acute phase reactants are associated with the severity of chronic obstructive pulmonary disease: a case-control study. Int J Med Sci. 2017;14:67–74.
   PubMed Web of Science ®Google Scholar
• Brzoska K, Bartlomiejczyk T, Sochanowicz B, et al. Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmonary disease subjects with lung cancer. Oncol Lett. 2018;16:6831–6837.
   PubMed Web of Science ®Google Scholar
• Thomsen M, Dahl M, Tybjaerg-Hansen A, et al. beta2 -adrenergic receptor Thr164IIe polymorphism, blood pressure and ischaemic heart disease in 66 750 individuals. J Intern Med. 2012;271:305–314.
   PubMed Web of Science ®Google Scholar
• Nielsen AO, Jensen CS, Arredouani MS, et al. Variants of the ADRB2 gene in COPD: systematic review and meta-analyses of disease risk and treatment response. COPD. 2017;14:451–460.
   PubMedGoogle Scholar
• Li JX, Fu WP, Zhang J, et al. A functional SNP upstream of the ADRB2 gene is associated with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:917–925.
   PubMed Web of Science ®Google Scholar
• Dowling RB, Johnson M, Cole PJ, et al. Effect of fluticasone propionate and salmeterol on Pseudomonas aeruginosa infection of the respiratory mucosa in vitro. Eur Respir J. 1999;14:363–369.
   PubMed Web of Science ®Google Scholar
• Wegner CD. Novel mechanistic targets for the treatment of sub-acute and chronic bronchitis. Curr Pharm Des. 2001;7:199–212.
   PubMed Web of Science ®Google Scholar
• Kulminski AM, Culminskaya IV, Ukraintseva SV, et al. Polymorphisms in the ACE and ADRB2 genes and risks of aging-associated phenotypes: the case of myocardial infarction. Rejuvenation Res. 2010;13:13–21.
   PubMed Web of Science ®Google Scholar
• Fang XY, Chen Z, Miao GB, et al. Expression of beta1- and beta2-adrenergic receptors in the lungs and changes in the levels of corresponding autoantibodies in an aged rat model of heart failure. Int J Mol Med. 2016;38:1933–1939.
   PubMed Web of Science ®Google Scholar
• Mei L, Huang C, Wang A, et al. Association between ADRB2, IL33, and IL2RB gene polymorphisms and lung cancer risk in a Chinese Han population. Int Immunopharmacol. 2019;77:105930.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu Y, Fu Q, et al. Inhibiting insulin-mediated beta2-adrenergic receptor activation prevents diabetes-associated cardiac dysfunction. Circulation. 2017;135:73–88.
   PubMed Web of Science ®Google Scholar
• Panebra A, Wang WC, Malone MM, et al. Common ADRB2 haplotypes derived from 26 polymorphic sites direct beta2-adrenergic receptor expression and regulation phenotypes. PLoS One. 2010;5:e11819.
   PubMed Web of Science ®Google Scholar
• Bristow M. Antiadrenergic therapy of chronic heart failure: surprises and new opportunities. Circulation. 2003;107:1100–1102.
   PubMed Web of Science ®Google Scholar
• Armaiz-Pena GN, Allen JK, Cruz A, et al. Src activation by beta-adrenoreceptors is a key switch for tumour metastasis. Nat Commun. 2013;4:1403.
   PubMed Web of Science ®Google Scholar
• Prior SJ, Goldberg AP, Ryan AS. ADRB2 haplotype is associated with glucose tolerance and insulin sensitivity in obese postmenopausal women. Obesity (Silver Spring). 2011;19:396–401.
   PubMed Web of Science ®Google Scholar
• Lacey RJ, Cable HC, James RF, et al. Concentration-dependent effects of adrenaline on the profile of insulin secretion from isolated human islets of Langerhans. J Endocrinol. 1993;138:555–563.
   PubMed Web of Science ®Google Scholar
• Xu F, Teng X, Yuan X, et al. LCK: a new biomarker candidate for the early diagnosis of acute myocardial infarction. Mol Biol Rep. 2014;41:8047–8053.
   PubMed Web of Science ®Google Scholar
• Vahedi S, Chueh FY, Chandran B, et al. Lymphocyte-specific protein tyrosine kinase (Lck) interacts with CR6-interacting factor 1 (CRIF1) in mitochondria to repress oxidative phosphorylation. BMC Cancer. 2015;15:551.
   PubMed Web of Science ®Google Scholar
• Jury EC, Kabouridis PS, Abba A, et al. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum. 2003;48:1343–1354.
   PubMed Web of Science ®Google Scholar
• Lin J, Weiss A. T cell receptor signalling. J Cell Sci. 2001;114:243–244.
   PubMed Web of Science ®Google Scholar
• Baniyash M. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol. 2004;4:675–687.
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645–2653.
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy TC, Ansari TW, Barnes NC, et al. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med. 1997;155:852–857.
   PubMed Web of Science ®Google Scholar
• Saetta M, Di Stefano A, Turato G, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:822–826.
   PubMed Web of Science ®Google Scholar
• Santamaria P. Effector lymphocytes in islet cell autoimmunity. Rev Endocr Metab Disord. 2003;4:271–280.
   PubMed Web of Science ®Google Scholar
• Hodge G, Nairn J, Holmes M, et al. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol. 2007;150:22–29.
   PubMed Web of Science ®Google Scholar
• Freeman CM, Han MK, Martinez FJ, et al. Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J Immunol. 2010;184:6504–6513.
   PubMed Web of Science ®Google Scholar
• Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med. 2007;13:567–569.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–1138.
   PubMed Web of Science ®Google Scholar
• Baines CP, Wang L, Cohen MV, et al. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning’s anti-infarct effect in the rabbit heart. J Mol Cell Cardiol. 1998;30:383–392.
   PubMed Web of Science ®Google Scholar
• Blum A, Yeganeh S. The role of T-lymphocyte subpopulations in acute myocardial infarction. Eur J Intern Med. 2003;14:407–410.
   PubMedGoogle Scholar
• Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32:962–969.
   PubMed Web of Science ®Google Scholar
• Ehrlich SF, Quesenberry CP Jr., Van Den Eeden SK, et al. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care. 2010;33:55–60.
   PubMed Web of Science ®Google Scholar
• Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61:284–289.
   PubMed Web of Science ®Google Scholar
• Parappil A, Depczynski B, Collett P, et al. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology. 2010;15:918–922.
   PubMed Web of Science ®Google Scholar
• Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793–1801.
   PubMed Web of Science ®Google Scholar
• Pradhan A. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutr Rev. 2007;65:S152–156.
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Luppi F, Beghe B, et al. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31:204–212.
   PubMed Web of Science ®Google Scholar
• Tkacova R. Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives. Mediators Inflamm. 2010;2010:585989.
   PubMed Web of Science ®Google Scholar
• Loganathan RS, Stover DE, Shi W, et al. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest. 2006;129:1305–1312.
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Christmas T, et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34:380–386.
   PubMed Web of Science ®Google Scholar
• Kiri VA, Soriano J, Visick G, et al. Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research Database. Prim Care Respir J. 2010;19:57–61.
   PubMedGoogle Scholar
• Young RP, Hopkins RJ, Hay BA, et al. Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Eur Respir J. 2008;32:1158–1164.
   PubMed Web of Science ®Google Scholar
• Young RP, Whittington CF, Hopkins RJ, et al. Chromosome 4q31 locus in COPD is also associated with lung cancer. Eur Respir J. 2010;36:1375–1382.
   PubMed Web of Science ®Google Scholar
• Punturieri A, Szabo E, Croxton TL, et al. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst. 2009;101:554–559.
   PubMed Web of Science ®Google Scholar
• Yao H, Rahman I. Current concepts on the role of inflammation in COPD and lung cancer. Curr Opin Pharmacol. 2009;9:375–383.
   PubMed Web of Science ®Google Scholar
• Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32:1371–1385.
   PubMed Web of Science ®Google Scholar
• Eickhoff P, Valipour A, Kiss D, et al. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178:1211–1218.
   PubMed Web of Science ®Google Scholar
• Peinado VI, Barbera JA, Ramirez J, et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol. 1998;274:L908–913.
   PubMed Web of Science ®Google Scholar
• Joppa P, Petrasova D, Stancak B, et al. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest. 2006;130:326–333.
   PubMed Web of Science ®Google Scholar
• Chaouat A, Savale L, Chouaid C, et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest. 2009;136:678–687.
   PubMed Web of Science ®Google Scholar